|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.4900 - 0.5200|
|52 Week Range||0.3920 - 5.3300|
|Beta (5Y Monthly)||1.73|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 11, 2019 - Nov 14, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
What a week for cannabis stocks! Finally rebounding, ETFs inched alongside many big companies in the industry. Over the last five trading days: The Horizons Marijuana Life Sciences Index ETF (OTC: HMLSF ...
MariMed Inc. (MRMD:OTCQX) (the “Company” or “MariMed”), a leading multi-state cannabis and hemp operator focused on health and wellness, is pleased to announce that Betty's Eddies™, its proprietary, in-house award-winning national cannabis brand, is now available in both Massachusetts Medical Cannabis and Adult-Use Cannabis Programs. One of the top performing cannabis brands in the United States, Betty's Eddies™ fruit chews are gluten-free, vegan, and produced with organically grown fruits and vegetables. Featuring a full spectrum cannabis oil, they are available in Multi-flavor packs, Betty’s Bedtime, Seasonal Apple Pie, as well as individual flavor packs.
MariMed Inc. (OTCQX: MRMD), a leading multi-state cannabis and hemp operator focused on health and wellness, today announced that Robert Fireman, Chief Executive Officer, will present live at VirtualInvestorConferences.com on January 9th.
MariMed Inc. (MRMD:OTCQX) a leading multi-state cannabis and hemp operator focused on health and wellness, announced today that their Illinois dispensaries in Anna and Harrisburg saw a significant uptick in sales on the first day under new laws to legalize recreational use of cannabis throughout the state. In May 2019, the Illinois General Assembly passed the HB 1438 law legalizing recreational cannabis use and sale in the state for adults which became effective January 1, 2020.
MariMed Inc. (MRMD:OTCQX), a leading multi-state cannabis and hemp operator focused on health and wellness, announced today that MariMed and GenCanna Global, Inc. (owned 33.5% by MariMed) are both expecting increased revenues in 2020. MariMed’s plan to consolidate the cannabis license companies it developed and manages is on track heading into 2020. To date, the Company has received state approval and has completed the transfer of licenses in Massachusetts and Illinois and approval from the State of Nevada is imminent.
MariMed Inc. (MRMD:OTCQX), a premier cannabis and hemp multi-state operator, received final authority from Massachusetts Cannabis Control Commission (CCC) to commence RMD operations at its Panacea Wellness Dispensary in Middleborough. ARL Healthcare Inc., a wholly-owned MariMed subsidiary, plans to open two additional dispensary licenses in Massachusetts. The Panacea Wellness Dispensary in Middleborough, MA will open for medical use on December 19, 2019, at 10 AM. New Panacea patients can register directly at the state-of-the-art facility at 29 Harding St. beginning that day.
MariMed Inc. (MRMD:OTCQX), a leading multi-state cannabis and hemp operator focused on health and wellness, today announced that its proprietary, in-house brand, Betty's Eddies™, is among the top-selling sublingual and edible products in a national survey conducted by LeafLink, the leading wholesale platform for cannabis products in the United States. On November 19, LeafLink released its second-annual LeafLink List, honoring the standout cannabis brands, products, and retailers on its B2B e-commerce marketplace, which processes over $1.4B per year in wholesale cannabis orders. MariMed, Inc. in-house brand Betty's Eddies™, which are gluten-free, vegan, and produced with organically grown fruits and veggies, is the LeafLink Winner for Best Selling Medical Product.
Cannabis Countdown: Top 10 Marijuana Stock News Stories of the Week Welcome to the Cannabis Countdown . In this week’s rendition, we’ll recap and countdown the top 10 marijuana stock news stories for ...
MariMed Inc. (MRMD:OTCQX) a leading multi-state cannabis and hemp operator focused on health and wellness, reported record results for both the three and nine-month periods ended September 30, 2019. Filing of the Company’s 10-Q for the quarter was delayed awaiting receipt from GenCanna Global, in which MariMed, Inc. holds a 33.5% interest, of its operating results for the quarter., As previously reported, GenCanna experienced a major fire at its Kentucky facility in early November. Of that total, cannabis revenues grew 24.1% to $4.21 million, while MariMed’s hemp division reported revenue primarily from seed sales, of $7.01 million in the quarter.
MariMed Inc. (MRMD) a leading multi-state cannabis operator focused on health and wellness, today announced that Dr. Jokūbas Žiburkus, chief innovation officer and Dr. Eva Selhub, an independent director on MariMed’s board, will participate as industry speakers at the Medical Cannabis Patient Therapies & Wellness Summit in Newton, MA November 14th and 15th.
MariMed Inc. (MRMD:OTCQX) a leading multi-state cannabis and hemp operator focused on health and wellness, today provided financial information for both the three and nine-month periods ended September 30, 2019. For the three months ended September 30, 2019, total revenues increased 231% to $11.22 million compared to the same period of 2018. This revenue was derived from management fees, licensing fees, and real estate income related to MariMed’s owned and/or operated cannabis facilities which grew 24% to $4.21 million in addition to $ 7.01 million from its Hemp business.
MariMed Inc. (MRMD:OTCQX), a premier cannabis and hemp multi-state operator, announced today that on November 7, 2019 the Massachusetts Cannabis Control Commission (CCC) approved ARL Healthcare to commence operations at its Cultivation and Production facility in New Bedford and its Dispensary in Middleborough.
NORWOOD, Mass., Oct. 31, 2019 -- MariMed Inc. (MRMD:OTCQX) today announced its chief innovation officer, Dr. Jokūbas Žiburkus, spoke at the European American Cannabis Business.
Bob Fireman, CEO and president of Marimed Inc (OTC: MRMD), began his presentation by highlighting the industry's responsibility to patients and their medical conditions. Children with epilepsy need precision-dosed products like MariMed's, the CEO said. Medical cannabis licensed producer Indiva Ltd (OTC: NDVAF) has consumer packaged goods executives who hail from major players, including NESTLE S A/S ADR (OTC: NSRGY), General Mills, Inc. (NYSE: GIS) and Clorox Co (NYSE: CLX).
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, has signed a definitive agreement to license its market leading brands and products, Betty’s Eddies™ and Kalm Fusion™, to Tropizen of Puerto Rico. Additionally, MariMed will become a licensee to manufacture and distribute Tropizen’s unique tropical products, Pique hot sauce and Real Fruit Gummies in the six states that MariMed serves in the US. Tropizen is a leading cultivator, manufacturer, distributor and retailer of cannabis products in Puerto Rico servicing nearly all of the island’s 100 dispensaries with world-class flower, edibles, topicals and concentrate products. Puerto Rico’s medical market is experiencing dynamic growth.
MariMed Inc. (MRMD) today announced that the Illinois Department of Financial and Professional Regulation has approved the transfer of ownership of its two cannabis-licensed clients, KPG Anna and KPG Harrisburg. The completion of these previously announced transactions will allow MariMed to report the operational results of these businesses in their consolidated financial statements effective October 1, 2019. This acquisition moves MariMed closer to the completion of the consolidation of its cannabis client businesses it developed and manages in multiple states.
Chicago, Illinois--(Newsfile Corp. - October 15, 2019) - MariMed Inc. (OTCQX: MRMD), will be presenting at the 5th Benzinga Cannabis Capital Conference in Chicago October 22-23 before an audience of well-vetted public and private companies, and an audience of fellow institutional, family office and accredited investors looking for the right opportunities in a crowded and volatile market. Investment opportunities abound. For more information and/or to register for the conference please visit: https://benzingacannabisconference.com/chicago/?utm_source=newsfile&utm_medium=press_release&utm_campaign=newsfileAbout the ConferenceThe ...
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, has appointed Phil Frankenberg as president of its MariMed Hemp subsidiary. MariMed Hemp develops industry-leading CBD brands, and markets them to retailers and direct to consumers worldwide. Frankenberg will focus on raising awareness and driving sales of MariMed Hemp’s top-quality hemp-derived CBD brands, including Florance™ and Healer.
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, has elected Eva Selhub, MD to its board of directors. Dr. Selhub, also known as Dr. Eva, is an internationally recognized resiliency expert, physician, author, speaker, scientist and consultant. Board certified in internal medicine, she has served as an instructor of medicine at Harvard Medical School.
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, announced that the HempEngine™ group of its MariMed Hemp subsidiary has signed an exclusive agreement with one of the largest beverage distributors located in the Northeast U.S., serving more than 8,500 on- and off-premise locations.
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, today announced its support of GenCanna Global USA’s engagement of Goldman Sachs & Co. LLC (Goldman Sachs) to serve as its financial advisor to assist in evaluating an initial public offering and other strategic financing alternatives. MariMed became GenCanna’s largest shareholder in February 2019 after making a significant investment to help fund GenCanna’s expansion of its Kentucky operations, and currently owns approximately one-third of the company. GenCanna’s Kentucky farmer’s network is proceeding with the harvest of over 7,000 acres of quality hemp plants which will be processed at GenCanna’s Winchester Kentucky processing center.
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, announced today its MariMed Hemp division will exhibit its Florance™ brand of CBD products at Natural Products Expo East being held at the Baltimore Convention Center on September 11-14, 2019. MariMed invites attendees to stop by the company’s booth #4902 where it will exhibit its full line of Florance Hemp CBD products in several categories, including health, beauty, pain and sports. Dr. Jokubas Zirbucus, MariMed’s chief innovation officer and one of the founders of the Florance brand, has organized an experienced medical team to develop new formulations that produce consistent and satisfying results for consumers and patients.
MariMed Inc. (MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, has received a special permit to allow its Panacea Wellness™ dispensary in Middleborough to merchandise cannabis products under the Massachusetts adult use program. It will now proceed at the Cannabis Control Commission (CCC) for adult use final approval. The dispensary has already received town approval for medical use.